Clinical Trial Update: Evaluation of Sentinel Node Policy in Early Stage Endometrial Carcinomas at Intermediate and High Risk of Recurrence. [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating sentinel lymph node policy in early-stage endometrial carcinoma at intermediate/high risk of recurrence; currently active but …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Carcinoma

Snippet

Sponsor: Centre Oscar Lambret | Conditions: Non Endometrioid Carcinoma, Endometrioid Carcinoma | Phase 3 | Status: ACTIVE_NOT_RECRUITING